Dietary fucoidan improves metabolic syndrome in association with increased Akkermansia population in the gut microbiota of high-fat diet-fed mice

详细信息    查看全文

• 作者：Qingsen Shang^a ; ^b ; ^{shangqingsen@163.com} ; Guanrui Song^a ; ^b ; ^{songguanrui122@163.com} ; Meifang Zhang^a ; ^b ; ^{zhangmeifang96@163.com} ; Jingjing Shi^a ; ^b ; ^{jingjshi@126.com} ; Cuiying Xu^a ; ^b ; ^{xucuiying78@163.com} ; Jiejie Hao^a ; ^b ; ^{2009haojie@ouc.edu.cn} ; Guoyun Li^a ; ^b ; ^{liguoyun@ouc.edu.cn} ; Guangli Yu^a ; ^b ; ^c ; ^{glyu@ouc.edu.cn}
• 关键词：Fucoidan ; Gut microbiota ; Metabolic syndrome ; Akkermansia ; Obesity
• 刊名：Journal of Functional Foods
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：28
• 期：Complete
• 页码：138-146
• 全文大小：1910 K
• 卷排序：28

文摘

Fucoidan reduces systematic inflammation and attenuates MetS in HFD-fed mice. Fucoidan increases Akkermansia population in the gut microbiota of mice with MetS. Fucoidan ameliorates MetS in association with a robust modulation of gut microbiota.